XML 22 R11.htm IDEA: XBRL DOCUMENT v3.26.3
Financial Instruments
9 Months Ended
Sep. 30, 2026
Investments, All Other Investments [Abstract]  
Financial Instruments

4. Financial Instruments

 

The following table summarizes the Company’s cash and cash equivalents, amortized cost, gross unrealized gains, gross unrealized losses, and fair value by significant category reported as cash and cash equivalents as of September 30, 2026, and December 31, 2025:

 

   September 30, 2026   December 31, 2025 
   Reported as:   Reported as: 
(in thousands)  Cash and Cash Equivalents   Cash and Cash Equivalents 
Cash  $2,002   $1,325 
Level 2          
Money market funds   1,974    12,096 
Subtotal   1,974    12,096 
Total assets measured at fair value  $3,976   $13,421 

 

Interest income recorded for these cash and investments was approximately $0.3 million and $0.5 million during the nine months ended September 30, 2026, and the year ended December 31, 2025, respectively.

 

As of September 30, 2026, and December 31, 2025, the Company did not have any financial assets classified as Level 1 or Level 3. The contingent consideration is carried at fair value and is a Level 3 financial liability. See further discussion of the contingent consideration in Note 3, Acquisitions and Note 12, Convertible Preferred Stock and Stockholders’ Equity under the subheading “Access Point Technologies Share Purchase Agreement”.